PharmaCielo Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PCLOF research report →
Price Chart
About the company
PharmaCielo Ltd. , operating alongside its subsidiary, specializes in the cultivation, processing, production, and distribution of medical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated products. In addition, the company provides telemedicine software solutions.
- CEO
- Marc Lustig
- IPO
- 2019
- Employees
- 268
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on PCLOF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $8.30M
- P/E
- -3.76
- Fwd P/E
- 0.34
- PEG
- -0.03
- P/S
- 5.19
- P/B
- -1.28
- EV/EBITDA
- -80.24
- Div Yield
- 0.00%
- Gross Margin
- 29.56%
- Op Margin
- -127.52%
- Net Margin
- -141.06%
- ROE
- 27.36%
- ROIC
- -39.66%
Latest fiscal year · YoY change
- Revenue
- $2.60M-25.2%
- Gross Profit
- $633.01K-13.4%
- Op Income
- $-3,849,437
- Net Income
- $-3,980,708+56.5%
- EPS
- $-0.01+90.0%
- OCF Growth
- +55.3%
- FCF Growth
- +55.3%
- 52W High
- $0.12
- 52W Low
- $0.00
- 50D MA
- $0.05
- 200D MA
- $0.05
- Beta
- 1.02
- RSI (14)
- 48
- Avg Volume
- 61.44K
No earnings-call transcripts are available for PCLOF yet.
- Free Float
- 95.9%
- Shares Outstanding
- 187.98M
- Float Shares
- 180.26M
Held by 1 ETFs
Biggest fund positions in PCLOF by dollar value.
Our PCLOF coverage
Recent articles, reports, and earnings notes.
No research on PCLOF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PCLOF report →PharmaCielo Announces 2026 Year-End Results
newsfilecorp.com · Jul 30
PharmaCielo Announces the Issuance of Interest Shares and Update on Insider Bridge Financing
newsfilecorp.com · May 19
PharmaCielo Announces Intention to Issue Interest Shares
newsfilecorp.com · Apr 17
PharmaCielo Announces the Issuance of Interest Shares
newsfilecorp.com · Mar 17
PharmaCielo Announces 2025 Q3 Results, AGM Details
newsfilecorp.com · Mar 2
PharmaCielo Announces Annual General Meeting and Intention to Issue Interest Shares
feeds.newsfilecorp.com · Feb 17
PharmaCielo Announces Revocation of FFCTO and Related Corporate Matters
newsfilecorp.com · Dec 30
PharmaCielo Completes La Margarita Land Sale, Repays Banco Agrario Loan, Strengthens Balance Sheet, Completes Audit
globenewswire.com · Oct 6
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.